NeuroClues
ProductPaidRevolutionize neurological diagnostics with advanced eye-tracking...
Capabilities9 decomposed
oculomotor-abnormality-detection-via-eye-tracking
Medium confidenceCaptures and analyzes eye movement patterns (saccades, smooth pursuits, fixations, nystagmus) using infrared corneal reflection tracking at 60-250Hz sampling rates to quantify deviations from normative oculomotor baselines. The system applies machine learning classifiers trained on neurologically-healthy control populations to detect subclinical abnormalities in eye-movement kinematics that precede visible neurological symptoms, enabling detection of early-stage neurodegenerative conditions like Parkinson's, cerebellar ataxia, and progressive supranuclear palsy before conventional clinical signs emerge.
Uses high-frequency infrared corneal reflection eye-tracking (60-250Hz) combined with machine learning classifiers trained on normative oculomotor baselines to detect subclinical neurological abnormalities invisible to human clinical observation, rather than relying on subjective bedside neurological examination or coarse video-based gaze estimation
Detects neurological abnormalities 6-18 months earlier than conventional clinical exams by quantifying subtle oculomotor changes, whereas traditional neurological testing relies on observable motor/cognitive deficits that emerge only after significant neuronal loss
longitudinal-oculomotor-decline-tracking
Medium confidenceStores baseline oculomotor metrics for individual patients and compares subsequent assessments against personalized baselines using statistical process control methods (e.g., exponentially-weighted moving average, control charts) to detect statistically-significant decline trajectories. The system generates alerts when oculomotor metrics deviate beyond patient-specific confidence intervals, enabling clinicians to quantify disease progression velocity and adjust therapeutic interventions based on objective biomarker trends rather than subjective symptom reports.
Applies statistical process control methods (control charts, EWMA) to individual patient baselines rather than population-level comparisons, enabling detection of patient-specific decline trajectories that may deviate from population norms due to genetic or disease heterogeneity
Provides objective, quantified disease progression metrics superior to subjective clinical rating scales (MDS-UPDRS, MMSE) which suffer from inter-rater variability and floor/ceiling effects, enabling earlier detection of therapeutic response or disease acceleration
multimodal-neurological-abnormality-classification
Medium confidenceIntegrates oculomotor metrics with optional supplementary neurological data (tremor accelerometry, gait kinematics, cognitive reaction times) into ensemble machine learning classifiers (random forests, gradient boosting, neural networks) trained on clinically-diagnosed patient cohorts to generate probabilistic diagnoses for specific neurological conditions. The system outputs condition-specific probability scores (e.g., 78% Parkinson's, 12% essential tremor, 10% other) with confidence intervals, enabling clinicians to rank differential diagnoses and prioritize confirmatory testing.
Combines oculomotor metrics with optional multimodal sensor data (tremor, gait, cognition) in ensemble classifiers trained on clinically-confirmed patient cohorts, rather than relying on single-modality biomarkers or population-level diagnostic criteria that lack individual patient specificity
Provides probabilistic differential diagnoses superior to rule-based diagnostic criteria (e.g., UK Parkinson's Disease Society Brain Bank criteria) which are binary and lack confidence quantification, enabling clinicians to make risk-stratified decisions about confirmatory testing
real-time-eye-tracking-data-acquisition-and-preprocessing
Medium confidenceCaptures raw eye-gaze coordinates and pupil diameter from infrared corneal reflection eye-tracker hardware at 60-250Hz sampling rates, applies real-time preprocessing (blink detection, saccade detection via velocity thresholding, fixation clustering, outlier removal) to clean noisy tracking data, and streams preprocessed gaze events to downstream analysis pipelines. The system implements hardware-specific calibration routines (9-point or 13-point grid calibration) and validates tracking quality metrics (gaze accuracy, precision, data loss rate) before accepting data for clinical analysis.
Implements hardware-specific calibration and real-time preprocessing pipelines (blink detection, saccade detection, fixation clustering) optimized for clinical eye-tracking hardware, with quality assurance metrics that validate tracking fidelity before data enters clinical analysis workflows
Provides clinical-grade eye-tracking data acquisition with real-time quality validation, superior to consumer-grade eye-tracking (e.g., webcam-based gaze estimation) which lacks hardware calibration, has 2-5x lower accuracy, and cannot reliably detect saccades or fixations
standardized-oculomotor-testing-protocol-execution
Medium confidenceImplements standardized visual stimulus presentation sequences (fixation tasks, smooth pursuit tasks, saccadic tasks, optokinetic nystagmus tasks) with precise timing control and stimulus geometry to elicit reproducible oculomotor responses across patients and assessment sessions. The system presents calibrated visual targets at defined eccentricities and velocities, records stimulus timing metadata, and ensures consistent task execution across different clinical sites through protocol validation and technician training modules.
Implements standardized oculomotor testing protocols with precise stimulus timing control and geometry validation, ensuring reproducible task execution across patients, sessions, and clinical sites — critical for longitudinal tracking and multi-site clinical trials
Provides protocol-driven stimulus presentation superior to ad-hoc bedside oculomotor testing, which lacks standardization, precise timing control, and reproducibility across assessments
normative-baseline-comparison-and-z-score-calculation
Medium confidenceCompares individual patient oculomotor metrics against age-stratified, ethnicity-stratified normative reference databases using z-score calculations to quantify deviation magnitude from healthy population norms. The system applies demographic-specific normalization (accounting for age-related oculomotor decline, sex differences, ethnic variation) and generates percentile ranks and confidence intervals around deviation scores, enabling clinicians to interpret whether observed oculomotor abnormalities are statistically significant or within normal variation.
Applies demographic-stratified normative comparison (age, ethnicity, sex) rather than single population-level norms, accounting for known oculomotor variation across demographic groups and reducing false-positive abnormality detection in normal ethnic variation
Provides objective, quantified abnormality detection via z-scores superior to subjective clinical interpretation of oculomotor findings, which is prone to inter-rater variability and cognitive biases
ehr-integration-and-clinical-report-generation
Medium confidenceExports oculomotor assessment results (metrics, diagnoses, longitudinal trends) in standardized clinical report formats compatible with electronic health record systems, including structured data fields (FHIR-compatible observations) and human-readable narrative summaries. The system generates PDF reports suitable for clinician review and EHR import, with embedded visualizations (metric trends, diagnostic probability charts) and recommendations for follow-up testing or therapeutic intervention.
Generates standardized clinical reports with structured FHIR-compatible data export for EHR integration, rather than standalone reports disconnected from clinical workflows — enabling seamless integration of oculomotor biomarkers into existing clinical decision-making processes
Provides EHR-integrated reporting superior to standalone assessment tools that generate isolated reports requiring manual data entry into EHR systems, reducing documentation burden and enabling longitudinal tracking within clinical workflows
quality-assurance-and-data-validity-monitoring
Medium confidenceMonitors eye-tracking data quality metrics in real-time (gaze accuracy, precision, data loss rate, tracking confidence) and flags assessment sessions with suboptimal data quality that may compromise diagnostic validity. The system implements automated quality checks (e.g., gaze accuracy >1.5 degrees triggers recalibration alert, data loss >10% triggers session rejection) and generates quality assurance reports documenting tracking performance and protocol compliance for each assessment session.
Implements real-time quality monitoring with automated alerts and session-level quality documentation, ensuring that only high-fidelity eye-tracking data enters clinical analysis pipelines — critical for diagnostic validity in clinical settings
Provides automated quality assurance superior to manual quality review, which is subjective and prone to inconsistency across technicians and sites, enabling standardized data quality across multi-site clinical trials
technician-training-and-competency-assessment
Medium confidenceProvides structured training modules for eye-tracking technicians covering hardware operation, calibration procedures, patient interaction, protocol execution, and troubleshooting common tracking failures. The system includes competency assessment tools (simulated patient scenarios, calibration accuracy tests, protocol compliance quizzes) to validate technician proficiency before independent clinical assessment execution, with ongoing competency monitoring through quality assurance metrics.
Implements structured technician training with competency assessment and ongoing performance monitoring, ensuring consistent assessment quality across technicians and sites — critical for multi-site clinical trials and healthcare system implementations
Provides systematic technician training superior to ad-hoc on-the-job training, which lacks standardization and may result in inconsistent assessment quality across technicians
Capabilities are decomposed by AI analysis. Each maps to specific user intents and improves with match feedback.
Related Artifactssharing capabilities
Artifacts that share capabilities with NeuroClues, ranked by overlap. Discovered automatically through the match graph.
Retinai
Enhance ophthalmology with AI-driven data management and...
YOLOv8
Real-time object detection, segmentation, and pose.
PP-LCNet_x1_0_textline_ori
image-to-text model by undefined. 1,86,085 downloads.
Looq AI
Revolutionize image analysis with advanced AI-powered recognition and...
Checkfirst
Revolutionizes inspection management with AI-driven automation and...
Qwen: Qwen3 VL 235B A22B Thinking
Qwen3-VL-235B-A22B Thinking is a multimodal model that unifies strong text generation with visual understanding across images and video. The Thinking model is optimized for multimodal reasoning in STEM and math....
Best For
- ✓Specialized neurology clinics with dedicated neuro-ophthalmology assessment capabilities
- ✓Academic medical centers conducting longitudinal neurodegenerative disease research
- ✓Clinical trial sites evaluating disease-modifying therapies where early biomarkers are critical
- ✓Neurology clinics managing chronic neurodegenerative diseases requiring objective progression monitoring
- ✓Clinical trial sites evaluating disease-modifying therapies where objective biomarkers replace subjective outcome measures
- ✓Patients with early-stage disease where subjective symptom progression is minimal but objective biomarker decline is detectable
- ✓General neurology clinics evaluating patients with suspected neurodegenerative disease where diagnostic uncertainty is high
- ✓Primary care settings lacking neuro-ophthalmology expertise, seeking objective diagnostic support
Known Limitations
- ⚠Requires controlled lighting environment (minimal glare, consistent illumination 300-500 lux) — field deployments or bedside assessments in variable lighting degrade tracking accuracy by 15-40%
- ⚠Hardware calibration drift occurs every 4-8 hours of continuous use, necessitating recalibration protocols that add 3-5 minutes per session
- ⚠Generalization limited to populations used in training datasets — performance degrades 8-15% for ethnic groups underrepresented in normative databases
- ⚠Cannot distinguish between primary oculomotor disorders (e.g., myasthenia gravis affecting extraocular muscles) and central neurological dysfunction without additional clinical context
- ⚠Requires patient cooperation and ability to follow visual targets — unreliable in patients with severe cognitive impairment, delirium, or inability to maintain fixation
- ⚠Requires minimum 2-3 assessments separated by 3-6 months to establish reliable decline trajectories — insufficient for acute diagnostic decisions
Requirements
Input / Output
UnfragileRank
UnfragileRank is computed from adoption signals, documentation quality, ecosystem connectivity, match graph feedback, and freshness. No artifact can pay for a higher rank.
About
Revolutionize neurological diagnostics with advanced eye-tracking technology
Unfragile Review
NeuroClues leverages sophisticated eye-tracking algorithms to detect neurological abnormalities with remarkable precision, offering clinicians an objective, non-invasive diagnostic complement to traditional neurological exams. The technology shows particular promise in identifying early-stage neurodegenerative conditions where subtle oculomotor changes precede obvious symptoms, though clinical adoption remains limited due to integration challenges with existing EHR systems.
Pros
- +Detects subclinical neurological changes through quantified eye-movement metrics that human observers miss, enabling earlier intervention windows
- +Non-invasive and rapid assessment (under 5 minutes) reduces patient burden compared to extensive neuropsychological testing batteries
- +Generates objective, reproducible data that removes subjective interpretation variability inherent in manual neurological examinations
Cons
- -Requires specialized hardware calibration and controlled lighting conditions, making deployment outside dedicated neurology centers impractical for many clinics
- -Evidence base remains limited to specific conditions; generalization to broader neurological populations and ethnic groups needs stronger clinical validation studies
Categories
Alternatives to NeuroClues
⭐AI-driven public opinion & trend monitor with multi-platform aggregation, RSS, and smart alerts.🎯 告别信息过载,你的 AI 舆情监控助手与热点筛选工具!聚合多平台热点 + RSS 订阅,支持关键词精准筛选。AI 智能筛选新闻 + AI 翻译 + AI 分析简报直推手机,也支持接入 MCP 架构,赋能 AI 自然语言对话分析、情感洞察与趋势预测等。支持 Docker ,数据本地/云端自持。集成微信/飞书/钉钉/Telegram/邮件/ntfy/bark/slack 等渠道智能推送。
Compare →The first "code-first" agent framework for seamlessly planning and executing data analytics tasks.
Compare →Are you the builder of NeuroClues?
Claim this artifact to get a verified badge, access match analytics, see which intents users search for, and manage your listing.
Get the weekly brief
New tools, rising stars, and what's actually worth your time. No spam.
Data Sources
Looking for something else?
Search →